Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)
Status:
Terminated
Trial end date:
2019-04-04
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if the study drug, Gedatolisib
(PF-05212384), given in combination with paclitaxel and carboplatin will work against
unresectable non-small cell lung cancer.